Search Results

GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry Approximately one-third of the drugs currently in clinical use are GPCR ligands. These scientists come from diverse fields such as medicine, agriculture, industrial chemicals, and data The C5a anaphylatoxin chemotactic receptor 1, also known as CD88, is part of the rhodopsin family of GPCRs Trends in GPCR Drug Discovery: New Agents, Targets and Indications.

#177 The Career That Was Never Planned To Focus on GLP-1 Hodson didn’t begin with the identity of “scientist GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Can GPCRs act as “delivery ZIP codes” for targeted therapies?

August 2022 "G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that serve Classically, GPCR internalization has been considered to lead to receptor desensitization. Here, this review summarizes different PTMs in GPCR internalization and analyzes their significance in , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural Why Predictive GPCR Modeling Matters Now The convergence of machine learning, improved GPCR structures For scientists, this is an intellectual challenge: demand more from your models.  Want to go deeper into GPCR modeling? Dr. collaboration. 🧠 Learn from the field’s top innovators. 📈 Sharpen your translational impact. 🔗 Connect with scientists

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR School of Medicine, has authored a new white paper in collaboration with Eurofins DiscoverX: Assess GPCR τ/KA) or log(max/EC50)) Systematic comparison of biased agonists using modern functional assays For scientists Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." GPCRs in the Background, But Always Present Even though his primary focus wasn’t GPCRs themselves, Serafini Takeaway Forget what you think you know about GPCR drug targets. data platform , GPCR training program , pain research , opioid signaling .

In GPCR drug discovery, a single mistaken assumption can derail an entire program. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you when irreversible binding, receptor reserve, or allosteric effects mimic classical patterns —leading scientists over upcoming topics Who it’s for:  drug discovery teams, pharmacologists refining their toolkit, and scientists Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate

— a transformation that reshaped how scientists design experiments and interpret signaling. When technology reduced the cost of failure, scientists could push boundaries faster. networks, biased signaling, and functional selectivity. For Early-Career Scientists: Don’t over-invest in proving your pipetting skills. Research Every generation of GPCR scientists inherits the tools of the last and builds the next.

GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

Exploring the intracellular allosteric site GPCRs represent one of the largest and most vital families For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in GPCR activity, enabling greater specificity and fewer side effects. allosteric site common in class A and class B GPCRs, particularly in chemokine receptors.

One fascinating aspect of the cellular signaling network is the crosstalk between G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). GPCRs, known for their involvement in a myriad of physiological processes, mediate mostly signaling through The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. , leading to segregation of RTK-to-Gαi pathways from canonical GPCR-to-Gαi pathways.

facilities for receptor assays PhD students trained across multiple techniques, not just one pipeline Senior scientists For Early-Career Scientists Don’t just pick a project — choose an ecosystem. What Changed After This Data The pooled funding model turned the lab into a magnet: postdocs, visiting scientists Timing, leadership alignment, and a critical mass of motivated scientists converged. GPCR Premium  for deep dives, strategic tools, and behind-the-scenes conversations shaping the GPCR field

What GPCR Biologic Drugs Reveal About the Active-State Problem Family B GPCRs are conformationally malleable Together, they form what receptor pharmacologists describe as affinity traps: distributed networks of has more trouble doing is stabilizing the specific active conformation that the full peptide contact network An allosteric modulator does not need to engage the orthosteric contact network at all. The orthosteric site at a family B GPCR is not closed to small molecules.

GPCR research requires turning data into insights for drug discovery Hi GPCR Friends, Every week, critical GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr. Expect a curated room of scientists, leaders, and investors ready to compare notes, spark collaborations GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need The pace of GPCR innovation is accelerating.

GPCR Event Highlight 11th Adhesion GPCR Workshop Hosted by the Adhesion GPCR Consortium, this event will Join fellow scientists and researchers in person to stay updated with adhesion GPCR biology. and Clinical Pharmacology 2026 GPCR Jobs NEW Postdoctoral Research Associate Senior Scientist - Discovery Biotherapeutics Post-Doctoral Fellow/Trainee Scientist; Biochemistry, Cellular and Mechanistic Pharmacology Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.

August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments Scientific insight, biosensors, and analytical methods are still evolving and should benefit from and Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR. , drug discovery, and biophysics, ensuring you don't miss crucial networking and learning opportunities Designed for GPCR scientists and translational teams, Premium keeps you informed on the science, careers GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need community platform to help train and inspire the next generation of scientists.” — Dr.

Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR podcast is now available! Our guest is Mark Schmeizl! Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

For drug discovery teams and scientists, staying ahead requires more than just reading papers—it demands and a research associate/scientist in in vitro pharmacology. scientists. of scientists. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

GPCR Ecosystem paid membership with extra benefits? 🔬Join the #GPCR movement today! ➡️ https://www.ecosystem.drgpcr.com/plans-pricing #gpcr #drgpcr

of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. GPCRs now have validated intracellular  allosteric sites. Subscribe to The Kenakin Brief today  ➤ #GPCRs #IntracellularDrugs #DiffusionBarriers #DrugResidenceTime

GPCR and global experts at the GPCR Drug Discovery session during Discovery on Target 2025—where groundbreaking GPCR Is in This Conversation At Dr. Over the years, we’ve built a global network of researchers, biotech leaders, and pharma innovators who Scientist GPCR pathways intersect with oncology, CNS, metabolic, cardiovascular, immunology, and fibrosis us at GPCR Happy Hour , where scientists, biotech leaders, CRO professionals, and investors from around

GPCR activation typically occurs through the binding of agonists which stabilize receptor conformations GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior Agonist binding to GPCRs doesn't always trigger all associated events sequentially. selectively activate specific cellular outcomes linked to that GPCR.

August 2022 "The common mechanisms by which members of the G protein-coupled receptor (GPCR) family respond However, it is becoming increasingly clear that GPCRs show great diversity in their intracellular location Here we will discuss recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact to generate specific spatiotemporal patterns of GPCR signaling in cells. Read more at the source #DrGPCR #GPCR #IndustryNews

Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface. During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Here, we reveal that the Smog GPCR transduces Fog signal to regulate Rho kinase accumulation and myosin Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Podcast is back this week with a brand new episode. Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics. https://buff.ly/32fzGbO #gpcr #drgpcr #podcast

GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Learn about his remarkable career and research in #GPCR signaling and trafficking. Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

Join us and learn how to quantify your kinetic GPCR signaling from the expert himself: Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

In order to expand its role in GPCRs, which antibodies tend to have more trouble binding to. How Fluorescent Ligands Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional ligands provide new capabilities: -            Real time tracking they allow continuous observation of GPCR conjunction with fluorescent tags to study biased signaling pathways, improving our understanding of GPCR Illuminating the life of GPCRs.